Literature DB >> 25348309

Diagnosis of HPV-negative, gastric-type adenocarcinoma of the endocervix.

Edyta C Pirog1.   

Abstract

Gastric-type adenocarcinoma of the cervix (GAS) is a novel, recently described subtype of endocervical adenocarcinoma. The clinical importance of accurate diagnosis of GAS stems from the observation that it confers worse prognosis than the usual-type endocervical adenocarcinoma. There are two unique characteristics of GAS: the tumor cells contain voluminous amounts of gastric-type mucins, and the tumor pathogenesis is not related to infection with high-risk human papillomavirus types. The histopathologic diagnosis of GAS is difficult; however, it may be confirmed by demonstration of intra-cytoplasmic gastric-type mucins using immunohistochemical staining with monoclonal antibody HIK1083. A protocol for HIK1083 immunostaining is described.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25348309     DOI: 10.1007/978-1-4939-2013-6_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Morphologic Features of Gastric-type Cervical Adenocarcinoma in Small Surgical and Cytology Specimens.

Authors:  Gulisa Turashvili; Elizabeth G Morency; Mihaela Kracun; Deborah F DeLair; Sarah Chiang; Robert A Soslow; Kay J Park; Rajmohan Murali
Journal:  Int J Gynecol Pathol       Date:  2019-05       Impact factor: 2.762

2.  Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers.

Authors:  Karl Ulrich Petry; Clemens Liebrich; Alexander Luyten; Martina Zander; Thomas Iftner
Journal:  Papillomavirus Res       Date:  2017-10-19

Review 3.  Untold story of human cervical cancers: HPV-negative cervical cancer.

Authors:  Jae-Eun Lee; Yein Chung; Siyeon Rhee; Tae-Hyung Kim
Journal:  BMB Rep       Date:  2022-09       Impact factor: 5.041

4.  Biology and treatment of cervical adenocarcinoma.

Authors:  Satoshi Takeuchi
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

5.  Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening.

Authors:  Michela Iacobellis; Cecilia Violante; Gabriella Notarachille; Angela Simone; Rosa Scarfì; Giuseppe Giuffrè
Journal:  Virol J       Date:  2018-03-20       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.